Pharmaceuticals, Biotechnology and Life Sciences
ProBiotix Health, a life sciences company developing clinically proven probiotic solutions to tackle chronic lifestyle diseases like high cholesterol, high blood pressure and atherosclerosis, has appointed Steen Andersen as Chief...
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Camzyos™ (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules) for the treatment...
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating 20th anniversary of FDA's approval of Botox Cosmetic.
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) 21 consortium have published a joint work plan until 2023....
Sanofi has launched its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors....
BAAR, Switzerland–(BUSINESS WIRE)–Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI…
–Phase 2 trial showed chemotherapy-free TUKYSA combination resulted in clinically meaningful and durable tumor responses– –Results presented in late-breaking oral…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in…
DUBLIN–(BUSINESS WIRE)–The “Good Documentation Practices” webinar has been added to ResearchAndMarkets.com’s offering. “Good Documentation Practices” is a “current” industry practice…
DUBLIN–(BUSINESS WIRE)–The “Regulatory Affairs Outsourcing Market – Global Outlook and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Branded Generics Market Research Report by Product (Trade Named Generics and Value-Added), Application, Distribution Channel, State – United…
DUBLIN–(BUSINESS WIRE)–The “South Korea Stem Cell Banking Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028” report has…
Meets the Growing Need for US-Based API Solubility and Bioavailability Enhancement Services QUAKERTOWN, Pa.–(BUSINESS WIRE)–Microsize today announced the launch of…
HIMALAYA Phase III trial subgroup analysis showed that IMFINZI plus tremelimumab improved overall survival vs. sorafenib in patients with unresectable…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–IgGenix, Inc., a biotechnology company taking a revolutionary approach to directly alleviate allergic disease, today announced…
